Protagonist Therapeutics Inc buy BMO Capital Markets
Start price
11.03.25
/
50%
€50.50
Target price
11.03.26
€66.33
Performance (%)
54.46%
Price
27.02.26
€78.00
This prediction will end soon
Summary
This prediction is currently active. With a performance of 54.46% the BUY prediction by BMO_Capital_Markets is a big success. This prediction currently runs until 11.03.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | 11.429% | 11.429% |
| iShares Core DAX® | -0,38 % | 2,61 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % |
| iShares S&P 500 | -0,71 % | -0,48 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at BMO Capital Markets from $62.00 to $72.00. They now have an "outperform" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€75.50
13.10.25
13.10.25
-
13.10.26
13.10.26
3.31%
27.02.26
27.02.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
06.12.24
06.12.24
€58.44
06.12.25
06.12.25
62.38%
07.12.25
07.12.25